主动脉瓣置换术后左心室重构、心肌纤维化与死亡率的性别差异
多中心观察性研究纳入674例重度主动脉瓣狭窄患者(男425例,女249例),行SAVR或TAVR,用心脏磁共振评估重构与LGE。中位随访3.6年,全因死亡率无显著性别差异,女性心血管死亡率更高;男性重构更进展,LGE与两性不良预后相关。
要点
- 女性TAVR比例更高且手术风险评分更高,男性二叶式主动脉瓣更多且重构更进展。
- 全因死亡率无显著性别差异,但女性心血管死亡率显著高于男性。
- LGE提示心肌纤维化,与两性全因及心血管死亡独立相关。
核心结论
- 男性对相似严重程度的主动脉瓣狭窄表现出更进展的左心室重构。
- 女性主动脉瓣置换术后心血管死亡率更高,可由女性二叶式主动脉瓣更少和风险评分更高导致更多TAVR来解释。
- LGE与两性更差预后相关。
研究设计与样本
- 多中心、观察性、结局研究,影像核心实验室分析。
- 英国六中心前瞻性招募拟干预的重度主动脉瓣狭窄患者,行心血管磁共振成像。
- 共纳入674例(男425例,女249例,年龄75±14岁),其中SAVR 399例、TAVR 275例。
- 主要终点为全因死亡,次要终点为心血管死亡。
主要发现
- 女性更年长、手术风险评分更高、更常接受TAVR(53% vs 33.6%,p<0.001)。
- 男性二叶式主动脉瓣更多(26.7% vs 14.9%,p<0.001)且重构更进展。
- 中位随访3.6年,145例(21.5%)死亡,全因死亡率无显著性别差异(23.3% vs 20.5%,p=0.114)。
- 女性心血管死亡率更高(13.7% vs 8.5%,p=0.012)。
- SAVR或TAVR亚组及排除二叶式主动脉瓣后,结局无显著性别相关差异。
关键数值与推荐
- 男性全因死亡独立相关因素:年龄、LVEF、二叶式主动脉瓣(更好)、LGE检测的心肌纤维化。
- 女性全因死亡独立相关因素:年龄、LVEF、LGE。
- 两性心血管死亡独立相关因素:年龄和LGE。
临床怎么用
- 评估主动脉瓣狭窄患者时应关注心肌纤维化(LGE),其与两性不良预后相关。
- 女性患者心血管死亡风险更高,需关注其更高手术风险评分和TAVR选择的影响。
- 男性患者即使狭窄程度相似,也可能已存在更进展的左心室重构。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate sex differences in left ventricular remodelling and outcome in patients undergoing surgical or transcatheter aortic valve replacement (SAVR/TAVR). METHODS: In this multicentre, observational, outcome study with imaging core-lab analysis, patients with severe aortic stenosis (AS) listed for intervention at one of six UK centres were prospectively recruited and underwent cardiovascular magnetic resonance imaging. The primary endpoint was all-cause mortality and secondary endpoint was cardiovascular mortality. RESULTS: 674 patients (425 men, 249 women, age 75±14 years) were included: 399 SAVR, 275 TAVR. Women were older, had higher surgical risk scores and underwent TAVR more frequently (53% vs 33.6%, p<0.001). More men had bicuspid aortic valves (BAVs) (26.7% vs 14.9%, p<0.001) and demonstrated more advanced remodelling than women. During a median follow-up of 3.6 years, 145 (21.5%) patients died, with no significant sex difference in all-cause mortality (23.3% vs 20.5%, p=0.114), but higher cardiovascular mortality in women (13.7% vs 8.5%, p=0.012). There were no significant sex-related differences in outcome in the SAVR or TAVR subgroups, or after excluding those with BAV. Factors independently associated with all-cause mortality were age, left ventricular ejection fraction (LVEF), BAV (better) and myocardial fibrosis detected with late gadolinium enhancement (LGE) in men, and age, LVEF and LGE in women. Age and LGE were independently associated with cardiovascular mortality in both sexes. CONCLUSIONS: Men demonstrate more advanced remodelling in response to a similar severity of AS. The higher cardiovascular mortality observed in women following AVR is accounted for by women having less BAV and higher risk scores resulting in more TAVR. LGE is associated with a worse prognosis in both sexes.
引用
- Singh A, Musa TA, Treibel TA, et al. Sex differences in left ventricular remodelling, myocardial fibrosis and mortality after aortic valve replacement. Heart. 2019. PMID: 31467152. doi:10.1136/heartjnl-2019-314987
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。